Uri Kopylov

Summary

Publications

  1. doi request reprint Obesity, metabolic syndrome and the risk of development of colonic diverticulosis
    Uri Kopylov
    Department of Gastroenterology and Hepatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Digestion 86:201-5. 2012
  2. doi request reprint Idiopathic liver function test abnormality in pregnancy is associated with assisted reproduction techniques
    Uri Kopylov
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Fertil Steril 99:377-81. 2013
  3. doi request reprint Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Inflamm Bowel Dis 18:2404-13. 2012
  4. doi request reprint Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines
    U Kopylov
    Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
    Aliment Pharmacol Ther 36:145-50. 2012
  5. doi request reprint Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Israel
    Inflamm Bowel Dis 18:1628-33. 2012
  6. doi request reprint Clinical and radiographic presentation of superior mesenteric vein thrombosis in Crohn's disease: a single center experience
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Israel
    J Crohns Colitis 6:543-9. 2012
  7. doi request reprint Head or tail: the orientation of the small bowel capsule endoscope movement in the small bowel
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Dig Dis Sci 57:694-8. 2012
  8. doi request reprint Travel-associated health risks for patients with inflammatory bowel disease
    Shomron Ben-Horin
    Gastroenterology Department, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Clin Gastroenterol Hepatol 10:160-5, 165.e1. 2012
  9. doi request reprint Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease
    Shomron Ben-Horin
    Department of Gastroenterology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Gastroenterol Hepatol 11:444-7. 2013
  10. doi request reprint Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease
    Shomron Ben-Horin
    Dept of Gastroenterology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Israel
    J Crohns Colitis 5:555-8. 2011

Collaborators

Detail Information

Publications17

  1. doi request reprint Obesity, metabolic syndrome and the risk of development of colonic diverticulosis
    Uri Kopylov
    Department of Gastroenterology and Hepatology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Digestion 86:201-5. 2012
    ....
  2. doi request reprint Idiopathic liver function test abnormality in pregnancy is associated with assisted reproduction techniques
    Uri Kopylov
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Fertil Steril 99:377-81. 2013
    ....
  3. doi request reprint Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Inflamm Bowel Dis 18:2404-13. 2012
    ..The aim was to evaluate the impact of preoperative treatment with anti-TNF antibodies on postoperative complications in CD patients undergoing abdominal surgery...
  4. doi request reprint Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines
    U Kopylov
    Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
    Aliment Pharmacol Ther 36:145-50. 2012
    ..Moreover, data on VZV immunity in adult IBD patients or accuracy of VZV serological testing under immunomodulator treatment is sparse...
  5. doi request reprint Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Israel
    Inflamm Bowel Dis 18:1628-33. 2012
    ....
  6. doi request reprint Clinical and radiographic presentation of superior mesenteric vein thrombosis in Crohn's disease: a single center experience
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Israel
    J Crohns Colitis 6:543-9. 2012
    ..This study describes the clinical and radiological characteristics of CD /patients with superior mesenteric vein thrombosis (MVT) diagnosed by CT/MRI...
  7. doi request reprint Head or tail: the orientation of the small bowel capsule endoscope movement in the small bowel
    Uri Kopylov
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Dig Dis Sci 57:694-8. 2012
    ..The aim of the study was to identify the orientation of the capsule along the migration through the small bowel...
  8. doi request reprint Travel-associated health risks for patients with inflammatory bowel disease
    Shomron Ben-Horin
    Gastroenterology Department, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Clin Gastroenterol Hepatol 10:160-5, 165.e1. 2012
    ..There are few data on risk of travel for patients with inflammatory bowel disease (IBD). We assessed rates of illness while traveling among patients with IBD...
  9. doi request reprint Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease
    Shomron Ben-Horin
    Department of Gastroenterology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Gastroenterol Hepatol 11:444-7. 2013
    ..The addition of immunomodulators to therapy might be helpful to patients who have lost response to anti-TNF agents owing to formation of antidrug antibodies...
  10. doi request reprint Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease
    Shomron Ben-Horin
    Dept of Gastroenterology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Israel
    J Crohns Colitis 5:555-8. 2011
    ..Limited data suggest the absence of infliximab in breast milk, thereby implying the safety of this drug during breast-feeding. We aimed to re-evaluate the presence of infliximab in breast milk of nursing IBD patients...
  11. doi request reprint The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
    Shomron Ben-Horin
    Department of Gastroenterology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Gut 60:41-8. 2011
    ..To localise the immunogenic part of infliximab and evaluate the clinical usefulness of measuring antibodies against infliximab fragments...
  12. doi request reprint Severe and morbid obesity in Crohn's disease patients: prevalence and disease associations
    Bella Ungar
    Department of Internal Medicine D, Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Digestion 88:26-32. 2013
    ..Crohn's disease (CD) is frequently associated with weight loss and malnutrition. However, as the prevalence of obesity increases worldwide, it may become a clinical problem even in CD...
  13. doi request reprint Optimizing anti-TNF treatments in inflammatory bowel disease
    Shomron Ben-Horin
    IBD Service, Department of Gastroenterology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Electronic address
    Autoimmun Rev 13:24-30. 2014
    ..Failure of anti-TNF treatment in inflammatory bowel disease (IBD) patients can take on several forms, each posing distinct etio-pathogenic considerations and management dilemmas...
  14. doi request reprint Magnetic resonance enterography in Crohn's disease: a guide to common imaging manifestations for the IBD physician
    Marianne M Amitai
    Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel Hashomer, Israel
    J Crohns Colitis 7:603-15. 2013
    ..This review is aimed to describe the indications for performing MRE in CD, essentials of MRE techniques and typical radiological findings in patients with CD to aid the IBD doctor in daily practice. ..
  15. pmc Cytomegalovirus positive ulcerative colitis: A single center experience and literature review
    Uri Kopylov
    Uri Kopylov, Gila Sasson, Rami Eliakim, Shomron Ben Horin, Department of Gastroenterology, Sheba Medical Center, Ramat Gan 52621, Israel
    World J Gastrointest Pathophysiol 4:18-23. 2013
    ..To compare the clinical outcome of cytomegalovirus (CMV)-positive ulcerative colitis (UC) patients with and without antiviral therapy...
  16. doi request reprint A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma
    Bella Geyshis
    Internal Medicine D, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
    J Crohns Colitis 7:e66-8. 2013
    ..Awareness of this condition as a cause of visual disturbance in IBD patients and a close ophthalmological cooperation are required in order to provide the optimal care for these patients...
  17. doi request reprint Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease
    Lael Werner
    Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    J Leukoc Biol 90:583-90. 2011
    ..Finally, T cells attracted by CXCL12 are mostly of a memory phenotype. In conclusion, the present study suggests that the interplay between CXCL12 and its receptors affects homeostasis and inflammation in the intestinal mucosa...